Pharmafile Logo
Pharmafocus logo
Advanced Search
takeda_world

Takeda partners with Zydus to develop chikungunya vaccine

September 20, 2016
Manufacturing and Production, Research and Development Takeda, Zydus Cadila, chikungunya

Zydus Cadila has teamed up with Takeda to develop a vaccine for the chikungunya virus. Zydus Cadila’s group firm Cadila …

News
2363

GSK appoints Emma Walmsley as CEO

September 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, appointment

GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …

News

Duchenne drug gets FDA approval in “unprecedented” ruling

September 20, 2016
Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, FDA, sarepta

The FDA has gone against the advice of its own staff to approve the first treatment of Duchenne muscular dystrophy …

News
Ian Parsons

PCI Pharma Services to Share Expertise at Free Serialization Forum

September 19, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI Pharma Services

Leading pharmaceutical outsourcing services provider PCI Pharma Services, in collaboration with Xytnek, Antares, and Healthcare Packaging magazine, will host a …

News
Press release

Ashfield and Patient Connect Form Alliance to Provide Holistic Patient Services

September 19, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield

Ashfield Commercial and Medical Services, part of UDG Healthcare plc, a global leader in providing outsourced healthcare services to pharmaceutical, …

News
Press release
roche__tree

NICE rejects expanded treatment indication for Roche’s Esbriet

September 19, 2016
Sales and Marketing Esbriet, NICE, Roche, rejection

NICE has published a final appraisal rejecting the expanded use of Roche’s Esbriet (pirfenidone) for the treatment of early idiopathic …

News
lilly_entrance_web

EU recommendation for Lilly’s soft tissue cancer drug

September 19, 2016
Sales and Marketing CHMP, EMA, Eli Lilly, Lartruvo, soft tissue sarcoma

The Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Lartruvo (olaratumab) for treatment of adults with …

News
jj_sign_on_wall

J&J in $4.33bn eye surgery unit acquisition

September 19, 2016
Manufacturing and Production, Sales and Marketing Abbott, Johnson & Johnson, acquisition

Johnson & Johnson has agreed to buy Abbott Laboratories’ eye surgery equipment unit in an all-cash deal for £4.33 billion …

News

“First of its kind” manufacturing campus to bring 500 jobs to Ireland

September 19, 2016
Manufacturing and Production, Sales and Marketing GE Healthcare, Ireland, manufacturing

Biopharma firm GE Healthcare has made a major investment to create a ‘BioPark’ in Ringaskiddy, Ireland, set to generate 500 …

News
shutterstock_274590824

Sanofi accuses MSD of US patent infringement

September 19, 2016
Sales and Marketing MSD, Sanofi, lawsuit

Sanofi has filed a suit against MSD in the United States District Court for the District of Delaware accusing the …

News
shutterstock_141299494

Precision medicine reveals ‘Achilles heel’ in chronic myeloid leukaemia

September 16, 2016
Medical Communications University of Glasgow, chronic myeloid leukaemia

Scientists at the University of Glasgow believe they have revealed an ‘Achilles heel’ of chronic myeloid leukaemia (CML), making their …

News
4420456374_64a3d7e6aa

Top Ten articles in the Pharma Industry this week

September 16, 2016
Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto

As we come to the end of another week, we’re looking back at an exciting week in the industry; there …

News
c_gajus_-_fotolia

Teva and Intel team up to tackle Huntington’s with wearable tech

September 16, 2016
Medical Communications Huntington's, Intel, Teva, wearable tech

Israeli pharma firm Teva is joining forces with technology giant Intel to tackle the debilitating disease Huntington’s with cutting-edge wearable …

News
shutterstock_512649

Dechra signs £31 million acquisition

September 16, 2016
Medical Communications Apex Laboratories, Dechra, acquisition

Dechra has agreed a deal to acquire veterinary pharmaceutical company Australian firm Apex Laboratories for AUS $55 (£31.3) million. The …

News
novo_corp_hq2

Novo Nordisk’s diabetes drug “significantly reduced’ cardiovascular risk

September 16, 2016
Medical Communications Novo Nordisk, diabetes, semaglutide

Novo Nordisk has announced that its diabetes drug semaglutide “significantly reduced” the risk of major cardiovascular events at the 52nd …

News
Cirrus

Cirrus – a new name for specialist artwork services

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Multi Packaging Solutions (“MPS”), a global leader in value-added print and packaging solutions for the pharmaceutical, healthcare and FMCG sectors, …

News
Press release
sanofi-dr-frank-nestle-250

New immunology and inflammation research global head and North American CSO for Sanofi

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, appointment

Sanofi has announced the appointment of Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic …

Appointment
eli_lilly_logo

Levi Garraway to succeed Richard Gaynor as senior VP of Global Oncology at Lilly

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

Eli Lilly has announced that Dr Levi Garraway will join the company as its senior vice president, Global Development & …

Appointment
allergan

Allergan snaps up Vitae Pharma for $639 million

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition

Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …

News
c_nito_-_fotolia

UK Biopharma and life after Brexit

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …

Feature
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026